• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Patient Values and Goals Regarding Treatment for Rectal Cancer: a Mixed Methods Study.

作者信息

Welten Vanessa M, Dabekaussen Kirsten F A A, Miller Miquell O, Yoo James, Irani Jennifer L, Goldberg Joel E, Bleday Ronald, Reich Amanda J, Davids Jennifer S, Melnitchouk Nelya

机构信息

Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, 75 Francis Street, Boston, 02115, MA, USA.

Center for Surgery and Public Health, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

出版信息

J Gastrointest Surg. 2023 Dec;27(12):3088-3091. doi: 10.1007/s11605-023-05818-2. Epub 2023 Oct 2.

DOI:10.1007/s11605-023-05818-2
PMID:37783908
Abstract
摘要

相似文献

1
Patient Values and Goals Regarding Treatment for Rectal Cancer: a Mixed Methods Study.直肠癌治疗的患者价值观与目标：一项混合方法研究。
J Gastrointest Surg. 2023 Dec;27(12):3088-3091. doi: 10.1007/s11605-023-05818-2. Epub 2023 Oct 2.
2
Conversations for providers caring for patients with rectal cancer: Comparison of long-term patient-centered outcomes for patients with low rectal cancer facing ostomy or sphincter-sparing surgery.为直肠癌患者提供护理的医护人员之间的对话：低位直肠癌患者面临造口术或保肛手术的长期以患者为中心的结局比较。
CA Cancer J Clin. 2016 Sep;66(5):387-97. doi: 10.3322/caac.21345. Epub 2016 Mar 21.
3
Shared Decision-Making for Rectal Cancer Treatment: A Path Forward.直肠癌治疗的共同决策：前进之路。
Dis Colon Rectum. 2019 Dec;62(12):1412-1413. doi: 10.1097/DCR.0000000000001454.
4
The evaluation of a rectal cancer decision aid and the factors influencing its implementation in clinical practice.直肠癌决策辅助工具的评估及其在临床实践中实施的影响因素。
BMC Surg. 2014 Mar 21;14:16. doi: 10.1186/1471-2482-14-16.
5
Patients, priorities, and decision making in T1 rectal cancer.T1期直肠癌患者、优先事项及决策制定
Dis Colon Rectum. 2013 Apr;56(4):397-9. doi: 10.1097/DCR.0b013e318280574a.
6
Do patients consider preoperative chemoradiation for primary rectal cancer worthwhile?患者是否认为原发性直肠癌的术前放化疗有价值？
Cancer. 2011 Jul 1;117(13):2853-62. doi: 10.1002/cncr.25842. Epub 2011 Jan 10.
7
Shared Decision Making for Rectal Cancer Care: A Long Way Forward.直肠癌护理中的共同决策：任重道远。
Dis Colon Rectum. 2016 Oct;59(10):905-6. doi: 10.1097/DCR.0000000000000663.
8
Surgical treatment of rectal cancer: radical resection.
Surg Oncol Clin N Am. 2006 Jan;15(1):95-107, vi-vii. doi: 10.1016/j.soc.2005.08.007.
9
Role of local excision in the management of rectal cancer: what does the future hold?
Tech Coloproctol. 2016 Nov;20(11):731-734. doi: 10.1007/s10151-016-1530-7. Epub 2016 Oct 20.
10
Patient-Reported Roles, Preferences, and Expectations Regarding Treatment of Stage I Rectal Cancer in the Cancer Care Outcomes Research and Surveillance Consortium.癌症护理结果研究与监测联盟中患者报告的关于I期直肠癌治疗的角色、偏好和期望。
Dis Colon Rectum. 2016 Oct;59(10):907-15. doi: 10.1097/DCR.0000000000000662.

本文引用的文献

1
Conditional recurrence-free survival of clinical complete responders managed by watch and wait after neoadjuvant chemoradiotherapy for rectal cancer in the International Watch & Wait Database: a retrospective, international, multicentre registry study.国际观察等待数据库中新辅助放化疗后观察等待管理的临床完全缓解者的无复发生存条件：一项回顾性、国际、多中心登记研究。
Lancet Oncol. 2021 Jan;22(1):43-50. doi: 10.1016/S1470-2045(20)30557-X. Epub 2020 Dec 11.
2
Quality of Life in Rectal Cancer Patients After Chemoradiation: Watch-and-Wait Policy Versus Standard Resection - A Matched-Controlled Study.直肠癌患者放化疗后的生活质量：等待观察策略与标准切除术的匹配对照研究
Dis Colon Rectum. 2017 Oct;60(10):1032-1040. doi: 10.1097/DCR.0000000000000862.
3
Total Neoadjuvant Therapy: A Shifting Paradigm in Locally Advanced Rectal Cancer Management.全新辅助治疗：局部进展期直肠癌治疗模式的转变。
Clin Colorectal Cancer. 2018 Mar;17(1):1-12. doi: 10.1016/j.clcc.2017.06.008. Epub 2017 Jun 27.
4
Organ Preservation in Rectal Adenocarcinoma: a phase II randomized controlled trial evaluating 3-year disease-free survival in patients with locally advanced rectal cancer treated with chemoradiation plus induction or consolidation chemotherapy, and total mesorectal excision or nonoperative management.直肠癌的器官保留：一项II期随机对照试验，评估接受放化疗加诱导或巩固化疗以及全直肠系膜切除术或非手术治疗的局部晚期直肠癌患者的3年无病生存率。
BMC Cancer. 2015 Oct 23;15:767. doi: 10.1186/s12885-015-1632-z.